Molecular and genomic characterisation of a panel of human anal cancer cell lines
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Molecular and genomic characterisation of a panel of human anal cancer cell lines
Authors
Keywords
-
Journal
Cell Death & Disease
Volume 12, Issue 11, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-10-19
DOI
10.1038/s41419-021-04141-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The repertoire of mutational signatures in human cancer
- (2020) Ludmil B. Alexandrov et al. NATURE
- Radiation resistance in head and neck squamous cell carcinoma: dire need for an appropriate sensitizer
- (2020) Marsha-Kay N. D. Hutchinson et al. ONCOGENE
- Prognostic value of the association between MHC class I downregulation and PD-L1 upregulation in head and neck squamous cell carcinoma patients
- (2019) Shin Hye Yoo et al. Scientific Reports
- Programmed Cell Death-Ligand 1 (PD-L1) Expression in Anal Cancer
- (2018) Rangaswamy Govindarajan et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Salvage Surgery for Locoregional Failure in Anal Squamous Cell Carcinoma
- (2018) Glen R. Guerra et al. DISEASES OF THE COLON & RECTUM
- E5 can be expressed in anal cancer and leads to epidermal growth factor receptor-induced invasion in a human papillomavirus 16-transformed anal epithelial cell line
- (2018) Erin Isaacson Wechsler et al. JOURNAL OF GENERAL VIROLOGY
- The alfa and beta of tumours: a review of parameters of the linear-quadratic model, derived from clinical radiotherapy studies
- (2018) C. M. van Leeuwen et al. Radiation Oncology
- Array comparative genomic hybridization identifies high level of PI3K/Akt/mTOR pathway alterations in anal cancer recurrences
- (2018) Wulfran Cacheux et al. Cancer Medicine
- Ki67 is a Graded Rather than a Binary Marker of Proliferation versus Quiescence
- (2018) Iain Miller et al. Cell Reports
- LBA21InterAACT: A multicentre open label randomised phase II advanced anal cancer trial of cisplatin (CDDP) plus 5-fluorouracil (5-FU) vs carboplatin (C) plus weekly paclitaxel (P) in patients (pts) with inoperable locally recurrent (ILR) or metastatic treatment naïve disease - An International Rare Cancers Initiative (IRCI) trial
- (2018) S Rao et al. ANNALS OF ONCOLOGY
- COSMIC: the Catalogue Of Somatic Mutations In Cancer
- (2018) John G Tate et al. NUCLEIC ACIDS RESEARCH
- RE: Anal cancer: different epidemiological and clinical definitions
- (2017) Farhad Islami et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- Nivolumab for previously treated unresectable metastatic anal cancer (NCI9673): a multicentre, single-arm, phase 2 study
- (2017) Van K Morris et al. LANCET ONCOLOGY
- Epidemiology of Anal Canal Cancer
- (2017) Valerie M. Nelson et al. Surgical Oncology Clinics of North America
- Roles of APOBEC3A and APOBEC3B in Human Papillomavirus Infection and Disease Progression
- (2017) Cody Warren et al. Viruses-Basel
- JAK Mutations as Escape Mechanisms to Anti–PD-1 Therapy
- (2017) Aurelien Marabelle et al. Cancer Discovery
- Exome sequencing reveals aberrant signalling pathways as hallmark of treatment-naive anal squamous cell carcinoma
- (2017) Wulfran Cacheux et al. Oncotarget
- Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden
- (2017) Zachary R. Chalmers et al. Genome Medicine
- Comprehensive genomic profiling of anal squamous cell carcinoma reveals distinct genomically defined classes
- (2016) J. H. Chung et al. ANNALS OF ONCOLOGY
- Mutational analysis of anal cancers demonstrates frequent PIK3CA mutations associated with poor outcome after salvage abdominoperineal resection
- (2016) Wulfran Cacheux et al. BRITISH JOURNAL OF CANCER
- Biomarkers in anal cancer: from biological understanding to stratified treatment
- (2016) Christopher M Jones et al. BRITISH JOURNAL OF CANCER
- Genomic Evolution after Chemoradiotherapy in Anal Squamous Cell Carcinoma
- (2016) Kent W. Mouw et al. CLINICAL CANCER RESEARCH
- FACETS: allele-specific copy number and clonal heterogeneity analysis tool for high-throughput DNA sequencing
- (2016) Ronglai Shen et al. NUCLEIC ACIDS RESEARCH
- VarDict: a novel and versatile variant caller for next-generation sequencing in cancer research
- (2016) Zhongwu Lai et al. NUCLEIC ACIDS RESEARCH
- Systematic Functional Characterization of Resistance to PI3K Inhibition in Breast Cancer
- (2016) X. Le et al. Cancer Discovery
- Genomic alterations in head and neck squamous cell carcinoma determined by cancer gene-targeted sequencing
- (2015) C. H. Chung et al. ANNALS OF ONCOLOGY
- Intramuscular Transplantation Improves Engraftment Rates for Esophageal Patient-Derived Tumor Xenografts
- (2015) Matthew Read et al. ANNALS OF SURGICAL ONCOLOGY
- HPV-negative squamous cell carcinoma of the anal canal is unresponsive to standard treatment and frequently carries disruptive mutations in TP53
- (2015) D Meulendijks et al. BRITISH JOURNAL OF CANCER
- 500 Pembrolizumab (MK-3475) for PD-L1-positive squamous cell carcinoma (SCC) of the anal canal: Preliminary safety and efficacy results from KEYNOTE-028
- (2015) P.A. Ott et al. EUROPEAN JOURNAL OF CANCER
- High-sensitivity human papilloma virus genotyping reveals near universal positivity in anal squamous cell carcinoma: Different implications for vaccine prevention and prognosis
- (2015) Ivona Baricevic et al. EUROPEAN JOURNAL OF CANCER
- APR-246 potently inhibits tumour growth and overcomes chemoresistance in preclinical models of oesophageal adenocarcinoma
- (2015) David S H Liu et al. GUT
- Molecular biology of anal squamous cell carcinoma: implications for future research and clinical intervention
- (2015) Maria-Pia Bernardi et al. LANCET ONCOLOGY
- Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer
- (2015) Edward B. Garon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Human papillomavirus DNA load and p16INK4aexpression predict for local control in patients with anal squamous cell carcinoma treated with chemoradiotherapy
- (2014) Franz Rödel et al. INTERNATIONAL JOURNAL OF CANCER
- APOBEC-Mediated Cytosine Deamination Links PIK3CA Helical Domain Mutations to Human Papillomavirus-Driven Tumor Development
- (2014) Stephen Henderson et al. Cell Reports
- Signatures of mutational processes in human cancer
- (2013) Ludmil B. Alexandrov et al. NATURE
- Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples
- (2013) Kristian Cibulskis et al. NATURE BIOTECHNOLOGY
- mTORC1 Inhibition Is Required for Sensitivity to PI3K p110 Inhibitors in PIK3CA-Mutant Breast Cancer
- (2013) M. Elkabets et al. Science Translational Medicine
- The Two Faces of Interferon- in Cancer
- (2011) M. R. Zaidi et al. CLINICAL CANCER RESEARCH
- Immunohistochemical staining patterns of p53 can serve as a surrogate marker for TP53 mutations in ovarian carcinoma: an immunohistochemical and nucleotide sequencing analysis
- (2011) Anna Yemelyanova et al. MODERN PATHOLOGY
- A framework for variation discovery and genotyping using next-generation DNA sequencing data
- (2011) Mark A DePristo et al. NATURE GENETICS
- The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data
- (2010) A. McKenna et al. GENOME RESEARCH
- Fast and accurate short read alignment with Burrows-Wheeler transform
- (2009) H. Li et al. BIOINFORMATICS
- Establishment and characterization of the human SaTM-1 anal canal squamous cell carcinoma cell line derived from lymph node metastasis
- (2009) Takeda INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More